Probiotics in the prevention of lung infection in patients on a ventilator.
Phase 3
- Conditions
- Health Condition 1: J159- Unspecified bacterial pneumonia
- Registration Number
- CTRI/2019/04/018659
- Lead Sponsor
- Fluid researchCMC vellore
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
APatients under department of medicine
BRequiring mechanical ventilation in medical wards, MHDU or MICU for more than 2 day
C Patients relatives are willing to provide informed consent.
Exclusion Criteria
A. Patientâ??s relatives not willing for informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ventilator associated pneumonia as defined by CDC guidelinesTimepoint: PATIENT WILL BE ASSESSED DAILY FOR DEVELOPING NEW VENTILATOR ASSOCIATED PNEUMONIA
- Secondary Outcome Measures
Name Time Method 1 mortality in each admission <br/ ><br>2 3 month mortality <br/ ><br>3 side effects each admission <br/ ><br>4 cost benefit analysis <br/ ><br>Timepoint: 10-30 days;5 no of ventilated days <br/ ><br>6 reintubation ratesTimepoint: 10-30 days;7 duration of ICU stayTimepoint: 10-30 days